Benzo[a]pyrene exacerbates atherosclerosis by upregulating SPP1 to promote macrophage inflammation and lipid dysregulation: An integrated network toxicology, RNA-seq, and experimental validation study
Vascular Pharmacology · 2026
DOI: 10.1016/j.vph.2026.107589 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Vascular Pharmacology, 2026. Verfasst von Runwen Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Diseases, Panzhihua Central Hospital, Panzhihua 617000, China. Hauptthemen laut MEDLINE: Benzo(a)pyrene, Atherosclerosis, Macrophages, Lipid Metabolism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Benzo[a]pyrene (BaP), a pervasive environmental pollutant, has been implicated in cardiovascular injury, yet its mechanistic contribution to atherosclerosis remains unclear. Here, we combined network toxicology, RNA-seq profiling, molecular simulations, and cellular validation to elucidate BaP-driven vascular effects. Integration of BaP-associated targets with atherosclerosis gene sets identified SPP1 as a key hub. Transcriptomic analysis of aortas from BaP-treated ApoE-/- mice revealed differential expression enriched in inflammatory responses, cytokine signaling, xenobiotic metabolism, and lipid-handling pathways. STRING-based protein interaction networks and Reactome analysis further supported coordinated activation of innate immunity and metabolic dysfunction. Molecular docking and 100-ns MD simulations demonstrated stable, energetically favorable binding between BaP and SPP1. In THP-1 macrophages, BaP enhanced oxLDL-induced SPP1 expression, reduced cell viability, and promoted a foam-cell-like phenotype characterized by suppressed ABCA1 and increased CD36 and PLIN2. Silencing SPP1 partially rescued BaP-induced cytotoxicity and lipid dysregulation, confirming SPP1's functional involvement. Collectively, these findings indicate that BaP aggravates atherosclerosis through SPP1-mediated macrophage inflammation and impaired lipid metabolism, highlighting SPP1 as a potential mechanistic link and therapeutic target for pollution-exacerbated vascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Diseases, Panzhihua Central Hospital, Panzhihua 617000, China.
- Department of Pharmacy, Cancer Hospital of Shantou University Medical College, China.
- School of Clinical Medicine, Tsinghua University, Beijing 102218, China.
- Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YG, UK. Electronic address: s.cai6@lancaster.ac.uk.
Zitieren
APA
Li, R., Zheng, J., Tang, Y., Liu, A., Liu, J., & Cai, S. (2026). Benzo[a]pyrene exacerbates atherosclerosis by upregulating SPP1 to promote macrophage inflammation and lipid dysregulation: An integrated network toxicology, RNA-seq, and experimental validation study. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2026.107589
Vancouver
Li R, Zheng J, Tang Y, Liu A, Liu J, Cai S. Benzo[a]pyrene exacerbates atherosclerosis by upregulating SPP1 to promote macrophage inflammation and lipid dysregulation: An integrated network toxicology, RNA-seq, and experimental validation study. Vascular Pharmacology. 2026. doi:10.1016/j.vph.2026.107589
BibTeX
@article{Li2026,
author = {Li, Runwen and Zheng, Jieting and Tang, Yongjiang and Liu, Aman and Liu, Jiang and Cai, Shanshan},
title = {Benzo[a]pyrene exacerbates atherosclerosis by upregulating SPP1 to promote macrophage inflammation and lipid dysregulation: An integrated network toxicology, RNA-seq, and experimental validation study},
journal = {Vascular Pharmacology},
year = {2026},
doi = {10.1016/j.vph.2026.107589}
}
EUVIMED